NeuBase Therapeutics Inc.

NAS: NBSE

GO
/marketstate/country/us

After Hours

/zigman2/quotes/206101919/composite

$

0.25

Change

+0.01 +4.29%

Volume

Volume 40,700

Feb 2, 2023, 4:42 p.m.

Real time quotes

/zigman2/quotes/206101919/composite

Today's close

$ 0.23

$ 0.24

Change

+0.0052 +2.24%

Day low

Day high

$0.21

$0.24

Open
Open: 0.22

52 week low

52 week high

$0.17

$2.08

Open

Market cap

$7.67M

Average volume

246,362

P/E ratio

N/A

Rev. per Employee

N/A

EPS

-1.03

Dividend

N/A

Div yield

N/A

Ex dividend date

N/A

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/us/nbse

MarketWatch News on NBSE

  1. NeuBase Therapeutics downgraded to perform from outperform at Oppenheimer

    6:28 a.m. Oct. 21, 2022

    - Tomi Kilgore

  2. NeuBase Therapeutics started at outperform with $14 stock price target at Oppenheimer

    7:40 a.m. Nov. 21, 2019

    - Tomi Kilgore

  3. Carnegie Mellon University Is a Big Backer of This Biotech Stock

    6:00 a.m. July 27, 2019

    - Barron's Online

  4. Ohr Pharmaceutical downgraded to hold from buy at Brean Capital

    7:38 a.m. Aug. 10, 2016

    - Tomi Kilgore

  5. Charting the Market

    12:10 a.m. July 18, 2015

    - Barron's Online

  6. In focus: New highs seem unlikely

    5:33 p.m. July 15, 2015

    - Lawrence G. McMillan

  7. Three health-care deals today are paying huge premiums

    8:26 a.m. March 31, 2015

    - Philip van Doorn

  8. Charting the Market

    11:40 p.m. March 6, 2015

    - Barron's Online

  9. Charting the Market

    11:32 p.m. June 27, 2014

    - Barron's Online

Analyst Ratings

/news/nonmarketwatch/company/us/nbse

Other News on NBSE

  1. 10-K: NEUBASE THERAPEUTICS, INC.

    7:59 a.m. Dec. 21, 2022

    - Edgar Online - (EDG = 10Q, 10K)

  2. NeuBase stock rises on gene editing research collaboration

    7:52 a.m. Oct. 21, 2022

    - Seeking Alpha

  3. Neubase Therapeutics (NBSE) Investor Presentation - Slideshow

    12:46 p.m. Oct. 5, 2022

    - Seeking Alpha

  4. NeuBase (NBSE) Moves to Buy: Rationale Behind the Upgrade

    11:00 a.m. Aug. 24, 2022

    - Zacks.com

  5. 10-Q: NEUBASE THERAPEUTICS, INC.

    7:09 a.m. Aug. 11, 2022

    - Edgar Online - (EDG = 10Q, 10K)

  6. 10-Q: NEUBASE THERAPEUTICS, INC.

    4:12 p.m. May 12, 2022

    - Edgar Online - (EDG = 10Q, 10K)

  7. 10-Q: NEUBASE THERAPEUTICS, INC.

    6:08 a.m. Feb. 11, 2022

    - Edgar Online - (EDG = 10Q, 10K)

  8. NeuBase Therapeutics GAAP EPS of -$0.24

    12:40 a.m. Feb. 11, 2022

    - Seeking Alpha

  9. NeuBase Therapeutics names Phathom's Todd Branning as new CFO

    4:10 p.m. Jan. 10, 2022

    - Seeking Alpha

  10. NeuBase Therapeutics reports FY results

    4:26 a.m. Dec. 27, 2021

    - Seeking Alpha

  11. Warning: NBSE is at high risk of performing badly

    4:20 a.m. Dec. 6, 2021

    - Seeking Alpha

  12. Tracking David Einhorn's Portfolio - Q3 2021 Update

    10:16 p.m. Nov. 17, 2021

    - Seeking Alpha

  13. Tracking David Einhorn's Portfolio - Q2 2021 Update

    1:00 a.m. Sept. 7, 2021

    - Seeking Alpha

  14. Loading more headlines...
/news/pressrelease/company/us/nbse

Press Releases on NBSE

  1. NeuBase to Participate at the Jefferies Healthcare Conference

    6:01 a.m. June 1, 2022

    - GlobeNewswire

Rates »

Link to MarketWatch's Slice.